Mario V. Fiorentino

3.0k total citations
80 papers, 1.7k citations indexed

About

Mario V. Fiorentino is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Mario V. Fiorentino has authored 80 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 16 papers in Molecular Biology. Recurrent topics in Mario V. Fiorentino's work include Lymphoma Diagnosis and Treatment (12 papers), Cancer Treatment and Pharmacology (11 papers) and Glioma Diagnosis and Treatment (9 papers). Mario V. Fiorentino is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Cancer Treatment and Pharmacology (11 papers) and Glioma Diagnosis and Treatment (9 papers). Mario V. Fiorentino collaborates with scholars based in Italy, France and United States. Mario V. Fiorentino's co-authors include Alba A. Brandes, Cristina Ghiotto, A. Fornasiero, Luigi Salvagno, Otello Daniele, E. Scelzi, Mario Ermani, Franco Berti, Paolo Zampieri and C. Carollo and has published in prestigious journals such as Journal of Clinical Oncology, Hepatology and Cancer.

In The Last Decade

Mario V. Fiorentino

73 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario V. Fiorentino Italy 23 554 452 322 320 306 80 1.7k
Liliana Montella Italy 23 594 1.1× 436 1.0× 222 0.7× 262 0.8× 305 1.0× 102 1.6k
Miriam Tucker United States 7 951 1.7× 401 0.9× 135 0.4× 524 1.6× 152 0.5× 8 1.9k
Ronald L. Stephens United States 24 1.3k 2.4× 648 1.4× 317 1.0× 394 1.2× 437 1.4× 83 2.6k
Giovannella Palmieri Italy 26 544 1.0× 432 1.0× 125 0.4× 364 1.1× 668 2.2× 113 1.9k
J J Shuster United States 25 334 0.6× 245 0.5× 205 0.6× 340 1.1× 556 1.8× 34 1.6k
A.J. Dembo Canada 29 530 1.0× 467 1.0× 110 0.3× 256 0.8× 190 0.6× 53 2.8k
Sarah Taylor United States 17 998 1.8× 681 1.5× 234 0.7× 227 0.7× 64 0.2× 38 1.9k
Robert S. Lavey United States 25 724 1.3× 498 1.1× 774 2.4× 520 1.6× 562 1.8× 52 2.5k
B.Y. Yeap United States 20 805 1.5× 1.0k 2.2× 295 0.9× 563 1.8× 227 0.7× 65 2.0k
Roland Guttenberger Germany 16 249 0.4× 434 1.0× 467 1.5× 124 0.4× 295 1.0× 37 1.3k

Countries citing papers authored by Mario V. Fiorentino

Since Specialization
Citations

This map shows the geographic impact of Mario V. Fiorentino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario V. Fiorentino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario V. Fiorentino more than expected).

Fields of papers citing papers by Mario V. Fiorentino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario V. Fiorentino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario V. Fiorentino. The network helps show where Mario V. Fiorentino may publish in the future.

Co-authorship network of co-authors of Mario V. Fiorentino

This figure shows the co-authorship network connecting the top 25 collaborators of Mario V. Fiorentino. A scholar is included among the top collaborators of Mario V. Fiorentino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario V. Fiorentino. Mario V. Fiorentino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Brandes, Alba A., Alberto Rigon, Paolo Zampieri, et al.. (1998). Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme. Cancer. 82(2). 355–361. 41 indexed citations
3.
Brandes, Alba A. & Mario V. Fiorentino. (1998). Clinical, pathological and therapeutic aspects of oligodendroglioma. Cancer Treatment Reviews. 24(2). 101–111. 5 indexed citations
4.
Brandes, Alba A. & Mario V. Fiorentino. (1997). Treatment of High-Grade Gliomas in the Elderly. Oncology. 55(1). 1–6. 22 indexed citations
5.
Brandes, Alba A., E. Scelzi, Paolo Zampieri, et al.. (1997). Phase II Trial with BCNU plus α-Interferon in Patients with Recurrent High-Grade Gliomas. American Journal of Clinical Oncology. 20(4). 364–367. 32 indexed citations
6.
Nicoletto, Maria Ornella, Salvatore Tumolo, Renato Talamini, et al.. (1997). Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.. Journal of Clinical Oncology. 15(3). 994–999. 33 indexed citations
7.
Paccagnella, Adriano, et al.. (1996). Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer: A phase II trial. Cancer. 78(8). 1701–1707. 7 indexed citations
8.
Scoazec, Jean‐Yves, Jean–François Fléjou, Antonietta D’Errico, et al.. (1996). Fibrolamellar Carcinoma of the Liver: Composition of the Extracellular Matrix and Expression of Cell–Matrix and Cell–Cell Adhesion Molecules. Hepatology. 24(5). 1128–1136. 27 indexed citations
9.
Tomio, L., A. Paccagnella, Lucio Loreggian, et al.. (1993). A Pilot Study of Concomitant Radiation and Chemotherapy in Patients with Locally Advanced Head and Neck Cancer. American Journal of Clinical Oncology. 16(3). 264–267. 6 indexed citations
10.
11.
Nicoletto, Ornella, et al.. (1992). Experience with Intraperitoneal Alpha-2a Interferon. Oncology. 49(6). 467–473. 6 indexed citations
12.
Fiorentino, Mario V. & Alba A. Brandes. (1992). Carboplatin plus 5-fluorouracil and leucovorin in previously treated patients with metastatic breast cancer. Annals of Oncology. 3. S29–S32. 8 indexed citations
13.
Celotti, Lucia, et al.. (1990). Effects of in vivo exposure to antineoplastic drugs on DNA repair and replication in human lymphocytes. Mutation Research Letters. 245(3). 217–222. 6 indexed citations
14.
Paccagnella, Adriano, Adolfo Favaretto, Alba A. Brandes, et al.. (1990). Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm. Cancer. 65(12). 2631–2634. 24 indexed citations
15.
Sarto, Fabio, Rosella Tomanin, Luciano Giacomelli, et al.. (1990). Evaluation of chromosomal aberrations in lymphocytes and micronuclei in lymphocytes, oral mucosa and hair root cells of patients under antiblastic therapy. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 228(2). 157–169. 71 indexed citations
16.
Fiorentino, Mario V., Otello Daniele, Paolo Morandi, et al.. (1988). Intrapericardial instillation of platin in malignant pericardial effusion. Cancer. 62(9). 1904–1906. 31 indexed citations
17.
Paccagnella, Adriano, Luigi Salvagno, Vanna Chiarion‐Sileni, et al.. (1986). Peptichemio in pretreated patients with plasmacell neoplasms. European Journal of Cancer and Clinical Oncology. 22(9). 1053–1058. 10 indexed citations
18.
Fornasiero, A., G. Cartei, Otello Daniele, Vinicio Fosser, & Mario V. Fiorentino. (1984). FAM2 Regimen in Disseminated Gastric Cancer. Tumori Journal. 70(1). 77–80. 9 indexed citations
19.
Fornasiero, A., Otello Daniele, Adriano Paccagnella, et al.. (1980). Tossicità della Bleomicina Somministrata in Infusione Continua ad Alte Dosi. Tumori Journal. 66(5). 607–613. 3 indexed citations
20.
Grigoletto, Eligio, et al.. (1971). Relapsing prostatic cancer.. BMJ. 1(5746). 459.2–459.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liliana Montella Breakdown of academic impact, for papers by Miriam Tucker Breakdown of academic impact, for papers by Ronald L. Stephens Breakdown of academic impact, for papers by Giovannella Palmieri Breakdown of academic impact, for papers by J J Shuster Breakdown of academic impact, for papers by A.J. Dembo Breakdown of academic impact, for papers by Sarah Taylor Breakdown of academic impact, for papers by Robert S. Lavey Breakdown of academic impact, for papers by B.Y. Yeap Breakdown of academic impact, for papers by Roland Guttenberger
Rankless by CCL
2026